Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription profiling of human HepG2 cell line challenged with a panel of pharmaceutical compounds to determine the impact of RNA quality on the expression

ABSTRACT: To determine the impact of RNA quality on the expression profiles generated by an in vitro HepG2 Cell line model to challenge with a panel of Pharmaceutical compounds.

ORGANISM(S): Homo sapiens

SUBMITTER: timothy wilkes

PROVIDER: E-MEXP-2297 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Transcription profiling of human HepG2 cell line challenged with Diazepampo determine the impact of RNA quality on the expression

Project description:To examine the impact of RNA integrity on the expression profile of model HepG2 cell system in response to challenge by a pharmaceutically active compound

2010-08-05 | E-MEXP-2299 | biostudies-arrayexpress

Transcription profiling of human HepG2 cell line exposed to aminocetophen - LGC_ACAP_WITHIN_RIN_DD4_Tox

Project description:To: (i)Determine the effect of sample RNA integrity as determined by RIN on an expression profile generated in a HepG2 cell line in response to challenge by a specific pharmaceutically active compound (acetaminophen). To:(ii)Determine the within RIN variability on an expression profile generated in a HepG2 cell line in response to challenge by a specific pharmaceutically active compound (acetaminophen).

2010-09-03 | E-MEXP-2346 | biostudies-arrayexpress

Transcription profiling of human HepG2 cell line response to challenge by a specific pharmaceutically active compound (Acetaminophen)LGC_ACAP__DD4_Tox

Project description:To determine the effect of sample RIN on an expression profile generated in a HepG2 cell line in response to challenge by a specific pharmaceutically active compound (Acetaminophen).

2010-08-27 | E-MEXP-2341 | biostudies-arrayexpress

Transcription profiling of human hepatic and pancreatic stellate cells obtained from tissues of chronic inflammation, and primary or metastatic cancers

Project description:Differences in the expression profile of hepatic and pancreatic stellate cells are investigated. Aim is to identify organ and disease specific transcriptome signatures of stellate cells, comparing hepatic and pancreatic stellate cells obtained from tissues of chronic inflammation, and primary or metastatic cancers of the pancreas. Tissues of chronic pancreatitis (n=6), pancreatic ductal adenocarcinoma (n=5), liver cirrhosis (n=5) and liver metastasis of pancreatic ductal adenocarcinoma (n=6) were collected and stellate cells were isolated by the outgrowth method. Using cDNA microarrays, differentially expressed genes are identified.

2010-01-15 | E-TABM-625 | biostudies-arrayexpress

MicroRNA profiling of human chorioamniotic membranes from women at term in labor, women at term not in labor and women who deliverd preterm

Project description:Comparing miRNAs expression levels in chorioamniotic membranes from women at term in labor (TL), women at term not in labor (TNL) and women who deliverd preterm (PTLC). The goal was to see if miRNA levels are indicators of preterm delivery or spontaneous labor at term. A two-channel technology was used in this experiment in which a pooled reference RNA was used for competitive hybridization. The pooled reference was generated at Exiqon in Denmark from a mixture of several human tissues (placenta, thyroid, brain, adipose, spleen, liver, colon, skeletal muscle, ovary, kidney, heart, cervix, testes, esophagus, small intestine, prostate, trachea, thymus, bladder, lung).

2008-10-01 | E-TABM-469 | biostudies-arrayexpress

Lapatinib-Induced Enhancement Of Mitochondrial Respiration In HER2-Positive SK-BR-3 Cells: Mechanism Revealed By Analysis Of Proteomic But Not Transcriptomic Data

Project description:Dual inhibitors of HER2 and EGFR, such as lapatinib, have shown significant efficacy for the therapy of HER2-positive breast cancer. Previous experiments showed that in cell cultures, the efficacy of lapatinib was significantly reduced by exposure to human serum and human epidermal growth factor (EGF). At the proteomic and transcriptomic levels, we examined the changes in the HER2-positive breast cancer cell line SK-BR-3 profiles upon treatment with lapatinib, either alone or in combination with human serum or EGF. Proteomic profiling revealed 350 differentially expressed proteins (DEPs) in response to lapatinib treatment at concentrations that induced cell growth arrest. Addition of human serum or EGF in combination with lapatinib prevented cell growth inhibition, and this combination treatment returned the expression of ~93% of DEPs to drug-free levels for both human serum and EGF. Gene ontology enrichment and OncoboxPD pathway activation level analysis showed that lapatinib addition influenced mostly common functional processes revealed in RNA- and protein-based assays. However, a specific feature was observed at the proteome level: addition of lapatinib increased the expression of proteins associated with mitochondrial function and cellular respiration. This feature was not observed when using RNA sequencing data for the same experiments. However, it is consistent with the results of the resazurin test, which showed a 1.8-fold increase in SK-BR-3 cellular respiration upon exposure to lapatinib. Thus, we conclude that enhanced cellular respiration is a novel additional mechanism of action of lapatinib on HER2-positive cancer cells.

2024-09-26 | PXD054180 | Pride

RNA-seq of triple cultures of neurons, astrocytes and microglia treated with blood clot conditioned media, lipopolysaccharide, and Nrf2-activating drug CDDO-TFEA.

Project description:Secondary injury causes death and dependence after spontaneous intracerebral haemorrhage (ICH). We found that myelomononuclear Nrf2 is active and protective after ICH in mice. To investigate the roles of myelomononuclear Nrf2 in modulating cell autonomous and non-cell autonomous responses to the oxidative and inflammatory consequences of ICH we developed an in vitro system of co-cultures of primary mouse microglia, human astrocytes and rat neurons and performed RNA-seq, subsequently performing in-silico separation of read data into separate species, and thus separate cell types. Cultures were treated with blood clot condition media (CCM), lipopolysaccharide (LPS), and Nrf2-activating drug CDDO-TFEA, and experiments were performed using wild-type mouse microglia, and microglia from mice with global Nrf2 deletion.

2024-08-13 | E-MTAB-14327 | biostudies-arrayexpress

Transcription profiling of mouse adipocytes to determine the role of RIP140 in adipocyte differentiation

Project description:Title: Gene Expression analysis of the role of RIP140 in adipocyte differentiation Description: RIPKO cells are mouse embryo fibroblasts (MEF) that were derived from RIP140-knockout mice and have been established as a RIP140 null cell line, while RIPKO-L7 and RIPKO-L16 are RIPKO cells for which the expression of RIP140 has been reintroduced using a lentiviral expression system. Using an established standard cocktail of hormones that includes IBMX, insulin, dexamethasone and a PPAR gamma agonist the cells were differentiated into adipocytes and RNA isolated at day 0 and day 10 after the addition of the cocktail.

2013-01-30 | E-MIMR-42 | biostudies-arrayexpress

Transcription profiling of rat differentiated RN46A cells after acute paroxetine exposure

Project description:Effect of acute paroxetine exposure on differentiated RN46A cells

2009-04-12 | E-MEXP-1582 | biostudies-arrayexpress

Transcription profiling of human hepatoma cell lines HepG2 and HepaRG using whole genome gene expression analysis before and after exposure to the GTX carcinogens AFB1 and BaP, and the NGTX carcinogens CsA, E2 and TCDD for 12 and 48 h

Project description:Direct comparison of the hepatoma cell lines HepG2 and HepaRG using whole genome gene expression analysis before and after exposure to the GTX carcinogens AFB1 and BaP and the NGTX carcinogens CsA, E2 and TCDD for 12 and 48 h.

2010-04-15 | E-MEXP-2458 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data